Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBY)

30.95
Delayed Data
As of Aug 29
 +0.16 / +0.52%
Today’s Change
29.89
Today|||52-Week Range
35.13
-10.21%
Year-to-Date
Stocks Stage Post-Yellen Rally With September Rate Hike in Focus
Aug 29 / TheStreet.com - Paid Partner Content
Roche Gets FDA Nod for Emergency Use of Zika Virus Test
Aug 29 / Zacks.com - Paid Partner Content
Stocks Rising as Wall Street Factors In Possible September Rate Hike
Aug 29 / TheStreet.com - Paid Partner Content
Stock Futures Flat as Investors Weigh Possible Rate Hike
Aug 29 / TheStreet.com - Paid Partner Content
Roche (RHHBY) Stock Higher, FDA Gives Emergency Approval for Zika Test
Aug 29 / TheStreet.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Monday
Aug 29 / TheStreet.com - Paid Partner Content
Stocks Extend Gains as Wall Street Mulls Possible Rate Hike
Aug 29 / TheStreet.com - Paid Partner Content
Roche Launches Accu-Chek Blood Glucose Monitoring System
Aug 23 / Zacks.com - Paid Partner Content
FDA Advises Zika Test for All U.S. Blood: Will Hologic Gain?
Aug 29 / Zacks.com - Paid Partner Content
Puma (PBYI) Neratinib's Application Validated in EU, Stock Up
Aug 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close30.79
Today’s open30.93
Day’s range30.86 - 31.02
Volume761,774
Average volume (3 months)986,111
Market cap$170.5B
Dividend yield3.29%
Data as of 08/29/2016

Growth & Valuation

Earnings growth (last year)-9.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.69%
Revenue growth (last year)-3.39%
P/E ratio--
Price/Sales4.76
Price/Book10.01

Competitors

No competitors data available.

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$0.92
Annual revenue (last year)$50.0B
Annual profit (last year)$9.2B
Net profit margin18.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
COO-
Roche Diagnostics Division
Roland Diggelmann
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Partner Offers

Search for Jobs